Global Anemia Therapeutic Drugs Market Research Report 2023

The global Anemia Therapeutic Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Anemia Therapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Anemia Therapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Anemia Therapeutic Drugs in Iron deficiency anemia is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Anemia Therapeutic Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Anemia Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anemia Therapeutic Drugs.

The Anemia Therapeutic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anemia Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anemia Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anemia Therapeutic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Supplements

1.2.3 Antibiotics

1.2.4 Immunosuppressant

1.2.5 Bone Marrow Stimulants

1.2.6 Corticosteroids

1.2.7 Gene Therapy

1.2.8 Iron Chelating Agents

1.3 Market by Application

1.3.1 Global Anemia Therapeutic Drugs Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Iron deficiency anemia

1.3.3 Thalassemia

1.3.4 Aplastic anemia

1.3.5 Hemolytic anemia

1.3.6 Sickle cell anemia

1.3.7 Pernicious anemia

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Anemia Therapeutic Drugs Market Perspective (2018-2029)

2.2 Anemia Therapeutic Drugs Growth Trends by Region

2.2.1 Global Anemia Therapeutic Drugs Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Anemia Therapeutic Drugs Historic Market Size by Region (2018-2023)

2.2.3 Anemia Therapeutic Drugs Forecasted Market Size by Region (2024-2029)

2.3 Anemia Therapeutic Drugs Market Dynamics

2.3.1 Anemia Therapeutic Drugs Industry Trends

2.3.2 Anemia Therapeutic Drugs Market Drivers

2.3.3 Anemia Therapeutic Drugs Market Challenges

2.3.4 Anemia Therapeutic Drugs Market Restraints

3.1 Global Top Anemia Therapeutic Drugs Players by Revenue

3.1.1 Global Top Anemia Therapeutic Drugs Players by Revenue (2018-2023)

3.1.2 Global Anemia Therapeutic Drugs Revenue Market Share by Players (2018-2023)

3.2 Global Anemia Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Anemia Therapeutic Drugs Revenue

3.4 Global Anemia Therapeutic Drugs Market Concentration Ratio

3.4.1 Global Anemia Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anemia Therapeutic Drugs Revenue in 2022

3.5 Anemia Therapeutic Drugs Key Players Head office and Area Served

3.6 Key Players Anemia Therapeutic Drugs Product Solution and Service

3.7 Date of Enter into Anemia Therapeutic Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Anemia Therapeutic Drugs Historic Market Size by Type (2018-2023)

4.2 Global Anemia Therapeutic Drugs Forecasted Market Size by Type (2024-2029)

5.1 Global Anemia Therapeutic Drugs Historic Market Size by Application (2018-2023)

5.2 Global Anemia Therapeutic Drugs Forecasted Market Size by Application (2024-2029)

6.1 North America Anemia Therapeutic Drugs Market Size (2018-2029)

6.2 North America Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Anemia Therapeutic Drugs Market Size by Country (2018-2023)

6.4 North America Anemia Therapeutic Drugs Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Anemia Therapeutic Drugs Market Size (2018-2029)

7.2 Europe Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Anemia Therapeutic Drugs Market Size by Country (2018-2023)

7.4 Europe Anemia Therapeutic Drugs Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Anemia Therapeutic Drugs Market Size (2018-2029)

8.2 Asia-Pacific Anemia Therapeutic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2018-2023)

8.4 Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Anemia Therapeutic Drugs Market Size (2018-2029)

9.2 Latin America Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Anemia Therapeutic Drugs Market Size by Country (2018-2023)

9.4 Latin America Anemia Therapeutic Drugs Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Anemia Therapeutic Drugs Market Size (2018-2029)

10.2 Middle East & Africa Anemia Therapeutic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2018-2023)

10.4 Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer, Inc.

11.1.1 Pfizer, Inc. Company Detail

11.1.2 Pfizer, Inc. Business Overview

11.1.3 Pfizer, Inc. Anemia Therapeutic Drugs Introduction

11.1.4 Pfizer, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.1.5 Pfizer, Inc. Recent Development

11.2 Amgen, Inc.

11.2.1 Amgen, Inc. Company Detail

11.2.2 Amgen, Inc. Business Overview

11.2.3 Amgen, Inc. Anemia Therapeutic Drugs Introduction

11.2.4 Amgen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.2.5 Amgen, Inc. Recent Development

11.3 Hoffmann-La Roche Ltd.

11.3.1 Hoffmann-La Roche Ltd. Company Detail

11.3.2 Hoffmann-La Roche Ltd. Business Overview

11.3.3 Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Introduction

11.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.3.5 Hoffmann-La Roche Ltd. Recent Development

11.4 Merck Sharp & Dohme Corp.

11.4.1 Merck Sharp & Dohme Corp. Company Detail

11.4.2 Merck Sharp & Dohme Corp. Business Overview

11.4.3 Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Introduction

11.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.4.5 Merck Sharp & Dohme Corp. Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Detail

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Anemia Therapeutic Drugs Introduction

11.5.4 Novartis AG Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.5.5 Novartis AG Recent Development

11.6 Janssen Pharmaceutical

11.6.1 Janssen Pharmaceutical Company Detail

11.6.2 Janssen Pharmaceutical Business Overview

11.6.3 Janssen Pharmaceutical Anemia Therapeutic Drugs Introduction

11.6.4 Janssen Pharmaceutical Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.6.5 Janssen Pharmaceutical Recent Development

11.7 Bayer AG

11.7.1 Bayer AG Company Detail

11.7.2 Bayer AG Business Overview

11.7.3 Bayer AG Anemia Therapeutic Drugs Introduction

11.7.4 Bayer AG Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.7.5 Bayer AG Recent Development

11.8 AMAG Pharmaceuticals

11.8.1 AMAG Pharmaceuticals Company Detail

11.8.2 AMAG Pharmaceuticals Business Overview

11.8.3 AMAG Pharmaceuticals Anemia Therapeutic Drugs Introduction

11.8.4 AMAG Pharmaceuticals Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.8.5 AMAG Pharmaceuticals Recent Development

11.9 GlaxoSmithKline plc

11.9.1 GlaxoSmithKline plc Company Detail

11.9.2 GlaxoSmithKline plc Business Overview

11.9.3 GlaxoSmithKline plc Anemia Therapeutic Drugs Introduction

11.9.4 GlaxoSmithKline plc Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.9.5 GlaxoSmithKline plc Recent Development

11.10 Akebia Therapeutics

11.10.1 Akebia Therapeutics Company Detail

11.10.2 Akebia Therapeutics Business Overview

11.10.3 Akebia Therapeutics Anemia Therapeutic Drugs Introduction

11.10.4 Akebia Therapeutics Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.10.5 Akebia Therapeutics Recent Development

11.11 Vifor Pharma Management, Ltd.

11.11.1 Vifor Pharma Management, Ltd. Company Detail

11.11.2 Vifor Pharma Management, Ltd. Business Overview

11.11.3 Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Introduction

11.11.4 Vifor Pharma Management, Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.11.5 Vifor Pharma Management, Ltd. Recent Development

11.12 FibroGen, Inc.

11.12.1 FibroGen, Inc. Company Detail

11.12.2 FibroGen, Inc. Business Overview

11.12.3 FibroGen, Inc. Anemia Therapeutic Drugs Introduction

11.12.4 FibroGen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023)

11.12.5 FibroGen, Inc. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Anemia Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Supplements

    Table 3. Key Players of Antibiotics

    Table 4. Key Players of Immunosuppressant

    Table 5. Key Players of Bone Marrow Stimulants

    Table 6. Key Players of Corticosteroids

    Table 7. Key Players of Gene Therapy

    Table 8. Key Players of Iron Chelating Agents

    Table 9. Global Anemia Therapeutic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Anemia Therapeutic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global Anemia Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)

    Table 12. Global Anemia Therapeutic Drugs Market Share by Region (2018-2023)

    Table 13. Global Anemia Therapeutic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 14. Global Anemia Therapeutic Drugs Market Share by Region (2024-2029)

    Table 15. Anemia Therapeutic Drugs Market Trends

    Table 16. Anemia Therapeutic Drugs Market Drivers

    Table 17. Anemia Therapeutic Drugs Market Challenges

    Table 18. Anemia Therapeutic Drugs Market Restraints

    Table 19. Global Anemia Therapeutic Drugs Revenue by Players (2018-2023) & (US$ Million)

    Table 20. Global Anemia Therapeutic Drugs Market Share by Players (2018-2023)

    Table 21. Global Top Anemia Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Therapeutic Drugs as of 2022)

    Table 22. Ranking of Global Top Anemia Therapeutic Drugs Companies by Revenue (US$ Million) in 2022

    Table 23. Global 5 Largest Players Market Share by Anemia Therapeutic Drugs Revenue (CR5 and HHI) & (2018-2023)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players Anemia Therapeutic Drugs Product Solution and Service

    Table 26. Date of Enter into Anemia Therapeutic Drugs Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Anemia Therapeutic Drugs Market Size by Type (2018-2023) & (US$ Million)

    Table 29. Global Anemia Therapeutic Drugs Revenue Market Share by Type (2018-2023)

    Table 30. Global Anemia Therapeutic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 31. Global Anemia Therapeutic Drugs Revenue Market Share by Type (2024-2029)

    Table 32. Global Anemia Therapeutic Drugs Market Size by Application (2018-2023) & (US$ Million)

    Table 33. Global Anemia Therapeutic Drugs Revenue Market Share by Application (2018-2023)

    Table 34. Global Anemia Therapeutic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 35. Global Anemia Therapeutic Drugs Revenue Market Share by Application (2024-2029)

    Table 36. North America Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Europe Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 41. Europe Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Asia-Pacific Anemia Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2018-2023) & (US$ Million)

    Table 44. Asia-Pacific Anemia Therapeutic Drugs Market Size by Region (2024-2029) & (US$ Million)

    Table 45. Latin America Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Latin America Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Latin America Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Middle East & Africa Anemia Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Middle East & Africa Anemia Therapeutic Drugs Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Pfizer, Inc. Company Detail

    Table 52. Pfizer, Inc. Business Overview

    Table 53. Pfizer, Inc. Anemia Therapeutic Drugs Product

    Table 54. Pfizer, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 55. Pfizer, Inc. Recent Development

    Table 56. Amgen, Inc. Company Detail

    Table 57. Amgen, Inc. Business Overview

    Table 58. Amgen, Inc. Anemia Therapeutic Drugs Product

    Table 59. Amgen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 60. Amgen, Inc. Recent Development

    Table 61. Hoffmann-La Roche Ltd. Company Detail

    Table 62. Hoffmann-La Roche Ltd. Business Overview

    Table 63. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Product

    Table 64. Hoffmann-La Roche Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 65. Hoffmann-La Roche Ltd. Recent Development

    Table 66. Merck Sharp & Dohme Corp. Company Detail

    Table 67. Merck Sharp & Dohme Corp. Business Overview

    Table 68. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Product

    Table 69. Merck Sharp & Dohme Corp. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 70. Merck Sharp & Dohme Corp. Recent Development

    Table 71. Novartis AG Company Detail

    Table 72. Novartis AG Business Overview

    Table 73. Novartis AG Anemia Therapeutic Drugs Product

    Table 74. Novartis AG Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 75. Novartis AG Recent Development

    Table 76. Janssen Pharmaceutical Company Detail

    Table 77. Janssen Pharmaceutical Business Overview

    Table 78. Janssen Pharmaceutical Anemia Therapeutic Drugs Product

    Table 79. Janssen Pharmaceutical Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 80. Janssen Pharmaceutical Recent Development

    Table 81. Bayer AG Company Detail

    Table 82. Bayer AG Business Overview

    Table 83. Bayer AG Anemia Therapeutic Drugs Product

    Table 84. Bayer AG Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 85. Bayer AG Recent Development

    Table 86. AMAG Pharmaceuticals Company Detail

    Table 87. AMAG Pharmaceuticals Business Overview

    Table 88. AMAG Pharmaceuticals Anemia Therapeutic Drugs Product

    Table 89. AMAG Pharmaceuticals Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 90. AMAG Pharmaceuticals Recent Development

    Table 91. GlaxoSmithKline plc Company Detail

    Table 92. GlaxoSmithKline plc Business Overview

    Table 93. GlaxoSmithKline plc Anemia Therapeutic Drugs Product

    Table 94. GlaxoSmithKline plc Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 95. GlaxoSmithKline plc Recent Development

    Table 96. Akebia Therapeutics Company Detail

    Table 97. Akebia Therapeutics Business Overview

    Table 98. Akebia Therapeutics Anemia Therapeutic Drugs Product

    Table 99. Akebia Therapeutics Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 100. Akebia Therapeutics Recent Development

    Table 101. Vifor Pharma Management, Ltd. Company Detail

    Table 102. Vifor Pharma Management, Ltd. Business Overview

    Table 103. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Product

    Table 104. Vifor Pharma Management, Ltd. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 105. Vifor Pharma Management, Ltd. Recent Development

    Table 106. FibroGen, Inc. Company Detail

    Table 107. FibroGen, Inc. Business Overview

    Table 108. FibroGen, Inc. Anemia Therapeutic Drugs Product

    Table 109. FibroGen, Inc. Revenue in Anemia Therapeutic Drugs Business (2018-2023) & (US$ Million)

    Table 110. FibroGen, Inc. Recent Development

    Table 111. Research Programs/Design for This Report

    Table 112. Key Data Information from Secondary Sources

    Table 113. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Anemia Therapeutic Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Anemia Therapeutic Drugs Market Share by Type: 2022 VS 2029

    Figure 3. Supplements Features

    Figure 4. Antibiotics Features

    Figure 5. Immunosuppressant Features

    Figure 6. Bone Marrow Stimulants Features

    Figure 7. Corticosteroids Features

    Figure 8. Gene Therapy Features

    Figure 9. Iron Chelating Agents Features

    Figure 10. Global Anemia Therapeutic Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global Anemia Therapeutic Drugs Market Share by Application: 2022 VS 2029

    Figure 12. Iron deficiency anemia Case Studies

    Figure 13. Thalassemia Case Studies

    Figure 14. Aplastic anemia Case Studies

    Figure 15. Hemolytic anemia Case Studies

    Figure 16. Sickle cell anemia Case Studies

    Figure 17. Pernicious anemia Case Studies

    Figure 18. Anemia Therapeutic Drugs Report Years Considered

    Figure 19. Global Anemia Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 20. Global Anemia Therapeutic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 21. Global Anemia Therapeutic Drugs Market Share by Region: 2022 VS 2029

    Figure 22. Global Anemia Therapeutic Drugs Market Share by Players in 2022

    Figure 23. Global Top Anemia Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Therapeutic Drugs as of 2022)

    Figure 24. The Top 10 and 5 Players Market Share by Anemia Therapeutic Drugs Revenue in 2022

    Figure 25. North America Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. North America Anemia Therapeutic Drugs Market Share by Country (2018-2029)

    Figure 27. United States Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Canada Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Europe Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Europe Anemia Therapeutic Drugs Market Share by Country (2018-2029)

    Figure 31. Germany Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. France Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. U.K. Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Italy Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Russia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Nordic Countries Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Asia-Pacific Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Asia-Pacific Anemia Therapeutic Drugs Market Share by Region (2018-2029)

    Figure 39. China Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Japan Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. South Korea Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Southeast Asia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. India Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Australia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Latin America Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Latin America Anemia Therapeutic Drugs Market Share by Country (2018-2029)

    Figure 47. Mexico Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Brazil Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Anemia Therapeutic Drugs Market Share by Country (2018-2029)

    Figure 51. Turkey Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Anemia Therapeutic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 53. Pfizer, Inc. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 54. Amgen, Inc. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 55. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 56. Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 57. Novartis AG Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 58. Janssen Pharmaceutical Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 59. Bayer AG Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 60. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 62. Akebia Therapeutics Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 63. Vifor Pharma Management, Ltd. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 64. FibroGen, Inc. Revenue Growth Rate in Anemia Therapeutic Drugs Business (2018-2023)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed